Home / Auditor changes / Benitec Biopharma Inc.

3/5Benitec Biopharma Inc. (BNTC): Auditor change

Filed 2026-09-30 路 Form 8-K 路 Accession 0001193125-26-409052

Verified excerpt

"(the "Company") filed on September 24, 2026, the Company reported the approval of the engagement of Ernst & Young LLP ("EY") as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2027."

Quoted from the filing. Source

What this means

The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.

Type: changed
Disagreements reported: no

Read the original filing on SEC.gov →

Not investment advice. Automated summary; verify against the filing.

Get the weekly "Red Flags" newsletter

The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.

Newsletter delivered by beehiiv. See our privacy policy.